Immuno US 2023

Featuring 30+ presentations, the event brings together over 120 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development.

Expand your knowledge & discuss future priorities in:

Discovery & Development: Cell Therapies & Antibody Approaches
Biomarkers, Precision Medicine & Spatial Biology in Immuno-Oncology
Discovery & Development: Intra-tumoral Immuno & Combination Therapies & Small Molecules as IO Therapies
Translational & Preclinical and Clinical Development

View the agenda here – https://www.oxfordglobal.co.uk/immuno-series-us/agenda/?utm_source=ebrc&utm_medium=eventlisting&utm_campaign=immuno&utm_content=immunous2023

Co-located with Biomarkers US 2023 attendees receive access to both events. For more information contact marketing@oxfordglobal.co.uk